Retraction of “Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis”
2019 ◽
Vol 33
(12)
◽
Keyword(s):
2015 ◽
Vol 25
(20)
◽
pp. 4601-4605
◽
2000 ◽
Vol 12
(sup3)
◽
pp. 215-223
◽
2005 ◽
Vol 25
(1_suppl)
◽
pp. S94-S94
Keyword(s):